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Objectives. To observe the short- and long-term outcomes after percutaneous coronary intervention (PCI) in octogenarians (> 80
y.o.) at our institution. Method. All octogenarians who underwent PCI during the study period were retrospectively retrieved
from our database and clinically followed. Major adverse cardiac (and cerebral) events (MAC(C)E) was considered as primary
outcome. Results. From January 2003 to December 2007, 140 octogenarians (mean age: 85±3 y.o., 79% of male) underwent PCI
and were clinically followed 14±11 months. Procedural success was obtained in 100 percent of patients with single vessel disease,
in 96 percent of patients with double vessel disease, and in 75 percent of patients with triple vessel disease. In-hospital, 30 days,
and one year MACE rates were 5%, 5%, and 10.7%, respectively. Impaired left ventricular (LV) ejection fraction (hazard ratio
(HR) = 0.909, 95% conﬁdence interval (CI) = 0.856 to 0.964, P = .002), diabetes mellitus (HR = 5.792, 95% CI = 1.785 to
18.796, P = .003), and low GFR (HR = 2.943, 95% CI = 1.161, to 7.464, P = .023) were independently associated with an
increase risk of MACE at long-term followup. Conclusion. Coronary angiography can be successfully performed in elderly patients
with single and double vessel disease. The results in triple vessel disease are encouraging. Low LV function, diabetes, and impaired
renal function increase the risk of long-term major adverse cardiac events.
1.Introduction
The proportion of older persons is increasing rapidly
throughout the world, which projected to more than double
worldwide over the next half century [1]. It is not surprising
that more and more elderly individuals are at increased
risk of coronary heart disease (CHD) and account for a
majority of CHD deaths. Data showed nearly 83% of all
CHD deaths and 88% of all stroke deaths are experienced
by persons aged 65 years and older [1]. As a consequence,
cardiologists are now encountering increasing numbers of
highly symptomatic elderly patients with serious cardiac
disease that warrants treatment. Advanced patient age,
however, may often make attending physicians reluctant to
pursue the necessary intervention of surgery or angioplasty.
Controversy exists as to whether the considerable proportion
of health care resources expended on the growing minority
ofveryelderlypatientsrepresentsacost-eﬀectiveapproachin
an attempt to maintain life at a meaningful level. Coronary
artery bypass surgery improves long-term survival, but is
associated with a high risk of perioperative morbidity and
mortality. Percutaneous coronary intervention (PCI) is a less
invasive procedure and could be an eﬀective alternative in
these elderly patients. However, the elderly patient has more
advanced coronary artery disease and more calciﬁed, or even
rigid and tortuous lesions. This makes coronary angioplasty
technically more diﬃcult to perform and may lead to less
satisfactory results [2]. At the same time, previous reports
have suggested that PCI in elderly patients is associated
with a higher complication rate [3–6]. It should be notice
that some of these large studies referred to [6, 7]h a v e
the limitation of being multicenter registries, where data
are self-reported and postinterventional complications could
have been upreported. A recent systematic review and meta-
analysis to evaluate the clinical outcome of patients aged 802 Cardiology Research and Practice
Table 1: Baseline clinical characters.
Age (years) (mean±SD) 85 ±3
Gender (n, % male) 110 (79%)
BMI (kg/m2) (mean±SD) 24.4 ±2.4
History of (n,% )
Hypertension 129 (92%)
Diabetes mellitus 53 (38%)
Cigarette smoking 15 (11%)
Hyperlipidaemia 32 (23%)
Stroke 11 (8%)
Myocardial infarction 20 (14%)
Angina pectoris 135 (96%)
Medications (n,% )
Aspirin 138 (99%)
Clopidogrel 6 (4%)
β-blocker 135 (96%)
ACEI/ARB 140 (100%)
Digitalis 10 (7%)
Diuretics 120 (86%)
Calcium channel blockers 4 (3%)
Nitrates 128 (91%)
Statin 140 (100%)
eGFR (ml/min) (mean±SD) 65.7 ±14.6
Fasting lipid values
Total cholesterol (mg/dL) (mean±SD) 192.2 ±27.4
Triglycerides (mg/dL) (mean±SD) 144.9 ±31.5
HDL (mg/dL) (mean±SD) 42.9 ±7.9
LDL (mg/dL) (mean±SD) 120.3 ±27.2
CCS(II/III/IV) (n,%) 12/82/5 (8%/59%/4%)
LVEF mean (%) (mean±SD) 46 ±10 (20–70)
<40% 45 (32%)
ACEI/ARB, angiotensin converting enzyme inhibitor/angiotensin II recep-
tor blocker; BMI, body mass index; eGFR, estimated glomerular ﬁltration
rate; SD, standard deviation.
years and older undergoing coronary revascularization indi-
cated clinical outcomes were similar for patients undergoing
PCI and CABG despite higher preprocedural risk among
patients undergoing PCI [8]. In this observational study,
we report the clinical outcomes of coronary angioplasties
between 2003 and 2007 for patients of 80 and older in the
daily clinical practice of a single center catheterization lab.
2. Methods
2.1. Characteristics. There are 3,000 patients who underwent
PCI since January 2003 till June 2007 at our institution.
The retrospective data of 140 consecutive patients aged
80 or more with stable, chronic coronary heart disease
were analyzed. The following characteristics were analyzed:
clinical presentation, previous cardiac history, risk factor
proﬁle, extent of coronary disease, and left ventricular
ejection fraction.
2.2. Procedure. Percutaneous transluminal coronary angio-
plasty (PTCA) was performed using standard technique
and a steerable catheter system. PTCA was attempted on
major coronary arteries which had 70 percent narrowing
diameter. Major arteries were deﬁned as the left anterior
descending and its large diagonal branches, the left circum-
ﬂex and its large obtuse marginal branches, and a balanced
or dominant right coronary artery. Patients who had a
chronictotalocclusioninonemajorcoronaryarteryorthose
with poor left ventricular function were excluded. However,
only patients with chronic total occlusion with favorable
angiographic characteristics had PTCA attempted.
Generally,ourstrategyhasbeentoattemptangioplastyof
all signiﬁcant stenoses during a single procedure whenever
possible. However, in some patients, PTCA was staged
as multiple procedures due to the unstable hemodynamic
condition of the patients or the excessive administration of
contrast.
If initially the patients’ condition was hemodynamically
unstable, only the culprit lesion was dilated. The culprit
lesion was determined on the basis of coronary angio-
graphic ﬁndings, electrocardiographic changes, and regional
ventricular function. All patients were treated with aspirin
300mg orally as the loading dosage and then 100mg daily.
Clopidogrel 300mg loading dose, followed by 75mg per day
was administered after stent placement for at least 9 month.
In the catherization laboratory, all patients were given 10000
units of heparin at the beginning of the procedure and
additional heparin was given if the procedure was prolonged.
After successful PTCA, low weight heparin was used for 3 to
5 days 100U/kg body weight routinely.
2.3. Deﬁnitions. Multivessel disease was deﬁned as a stenosis
of ≥70 percent in at least two major vessels. Procedural
success was deﬁned as a reduction to residual stenosis of
<40% by balloon angioplasty or successful stent deployment
at the desired position with a residual stenosis <20% by
visual assessment in multiple projections. Clinical success
was deﬁned as procedural success plus the absence of major
adverse cardiac events (MACE) while in hospital for the
index PCI—that is, myocardial infarction, the need for
repeated revascularization, coronary artery bypass grafting
(CABG), or death.
Complete revascularization was deﬁned as successful
dilation of all initial stenosis ≥70 percent. Incomplete revas-
cularization was considered to be a successful angioplasty of
o n eo rm o r es t e n o s e sb u tw i t ho n eo rm o r er e s i d u a ls t e n o s e s
of 70 percent remaining.
2.4. Followup. Clinical followup was obtained when patients
were seen at the outpatient clinic or by direct telephone
interview. Adjunctive information was obtained from the
referring physician. Followup information included the
following: current angina status, history of myocardial
infarction since the initial angioplasty procedure, need for
additional revascularization procedure (bypass surgery or
repeated angioplasty), and death (cardiac or noncardiac).
Furthermore, activity status was assessed by the patients’Cardiology Research and Practice 3
subjective impression when compared with activities prior
to PTCA.
2.5. Statistical Analysis. Continuous variables are presented
as mean ± SD. A multivariable Cox proportional hazard
model was used to assess the predictors of MAGE after PCI.
Variables included in the multivariate model were patient
related factors. A P-value <. 05 was considered signiﬁcant.
3. Results
3.1. Clinical and Angiographic Characteristics. One hundred
and forty consecutive patients > 80 years old (110 men),
with a median age of 85 years (range 80–93 years), under-
went intervention during the study period. Baseline clinical
characteristics are shown in Table 1. Seventy eight of 140 of
patients had multivessel disease, 32 had three vessel coronary
disease, 46 two vessel coronary disease, and 62 single vessel
coronary disease. Left ventricular fraction 40 percent was
present in 45 (32 percent) patients.
3.2. Initial Results. A total of 246 lesions were treated.
Procedural success was obtained in 100 percent of patients
with single vessel disease, in 96 percent of patients with
double vessel disease, and in 75 percent of patients with
triple vessel disease. Four total coronary occlusions were
not attempted. The strategy for revascularization was PTCA
alone in 7 patients, PTCA and stenting in 126 patients and
direct stenting in 3 patients.
Technical success was obtained in 126 patients with the
success rate highest in patients with single vessel disease and
lowest in patients with triple vessel disease. In patients with
singlevesseldisease,completerevascularizationwasobtained
in 100 percent. However, because of old total coronary
occlusion or diﬀuse of disease in another artery, 69 percent
of patients achieved complete revascularization with triple
vessel disease, and 93 percent with two vessel disease.
β-blockers, angiotensin converting enzyme
inhibitors/angiotensin II receptor blockers, and statin
agents were administrated to all patients after PTCA if no
contradiction existed.
3.3. Complications. In-hospital MACE rate was 7/140
(Table 1). The complication rate was highest among those
patients who presented with severe coronary artery disease.
The median time from procedure to discharge was 6 (3–
25) days. Major hemorrhagic complications did not occur
in any of the patients before discharge. None of the patients
developed stroke, whereas two patients developed transient
worsening renal dysfunction that resolved without the need
for dialysis.
3.4. Late Results. Follow-up information was obtained on
97% patients. The mean follow-up time was 14 ±11 months
(range 3 to 45 months). The 30-day and one-year MACE
rate was 5.0% and 10.7%, respectively (Table 2). The cause
of death was deﬁnite myocardial infarction in six patients,
congestive cardiac failure in 2 patients, and noncardiac death
Table 2: Major adverse cardiac events.
In-hospital
n (%)
30 days
n (%)
1 year
n (%)
Death 4 (2.9) 2 (1.4) 1 (0.7)
Myocardial infarction 0 (0) 2 (1.4) 1 (0.7)
Repeat PCI 0 (0) 1 (0.7) 13 (9.3)
CABG 3 (2.1) 2 (1.4) 0 (0)
Total 7 (5.0) 7 (5.0) 15 (10.7)
CABG:Coronaryarterybypassgraft;PCI:Percutaneouscoronaryinterven-
tion.
Table 3: Multivariate Predictors of MACE after PCI.
Predictors of MACE HR 95% CI P value
LV Ejection fraction 0.909 0.856–0.964 .002
Diabetes mellitus 5.792 1.785–18.796 .003
eGFR 2.943 1.161–7.464 .023
CI, conﬁdence interval; eGFR, estimated glomerular ﬁltration rate; HR,
hazard ratio; LV, left ventricular; MACE, major adverse cardiac events.
in 1 patient. In patients who died within 30 days of the
procedure, ﬁve of six had had a recent myocardial, ejection
fraction was <40% in four of six patients, and PCI had failed
in two patients.
Sixty four percent patients were subjectively improved
at either the same or higher level of activity. Either within
patients with clinical success or within patients without
clinicalimprovement,thecardiaceventsweremorecommon
among patients with three-vessel disease or poor left ventric-
ular function. Two patients had nondisabling stroke during
followup, and one patient had a nonfatal gastrointestinal
hemorrhage.
MultivariateCoxproportionalhazardsanalysisidentiﬁed
impaired LVEF (hazard ratio (HR) = 0.909, 95% conﬁdence
interval (CI) = 0.856 to 0.964, P = .002), diabetes mellitus
(HR = 5.792, 95% CI = 1.785 to 18.796, P = .003), and low
GFR (<60cc/min/1.73m2)( H R= 2.943, 95% CI = 1.161
to 7.464, P = .023) to be independently associated with an
increased risk of MACE (Table 3).
3.5. Discussion. Recently, there has been a marked aging
of the population, and concurrently, the treatment strategy
for coronary heart disease in elderly patients has become
more aggressive [1], especially in developing countries,
such as China [4, 7, 9–11]. This is because not only
these patients’ life span has been prolonged but also there
have been improvements in medical treatment in elderly
patients. However, medical treatment is not always able
to control symptoms and is sometimes poorly tolerated.
In speciﬁc high risk subsets, medical therapy alone is
not able to improve. PCI has been utilized for coronary
revascularization for 30 years since the ﬁrst application by
Andreas Gruentzig in Zurich in 1977 [12]. Previous reports
showed that these patients are at a high-risk because the
major cardiac complications are higher than in younger
patients. The elderly patients usually have more severe
symptoms [13]. They frequently present with acute coronary4 Cardiology Research and Practice
syndrome. There are more patients with multiple-vessel
diseases and more calciﬁcation on the coronary lesions and
they are more commonly with comorbid conditions [14, 15].
Compared with younger patients, the elderly patients usually
received incomplete revascularization. However, complete
revascularization may not be necessary if the primary goal
is to achieve symptomatic relief and coronary angioplasty
can be performed safely and provides good symptomatic
relief and favorable long-term outcome in old people over
70 years [16]. Furthermore, nowadays, in the era of stenting,
multivessel disease and complex coronary anatomy, such as,
chronic total occlusion, bifurcation lesions, heavily calciﬁed
lesions, oriﬁce lesions, coronary graft lesions, left main
stem lesions and smaller vessels are all candidate targets
for intervention when indicated. Poor general conditions,
such as acute myocardial infarction, heart failure or even
cardiogenic shock are also proved to gain beneﬁts from the
interventions [17].
Our data showed that PTCA and stent can be done
with high clinical success in elderly patients. Furthermore, in
patients with multivessel disease, complete revascularization
is still very high. The most common reasons for incomplete
revascularization were long-term total occlusions and diﬀuse
disease. In accordance with the literature, for patients at
high risk in the presence of multivessel disease and low left
ejection fraction, clinical success varies from 57 percent to
93 percent, and the inhospital mortality rate varies from 0.9
percent to 19 percent. These variabilities are probably due to
patient selection and diﬀerent populations studied. Recent
reports on PTCA in patients with multivessel disease show
that elderly patients frequently have incomplete revascular-
ization and a higher rate of major cardiac complications
because of the presence of severe coronary disease and/or
low left ejection fraction. However, the use of the stent
could possibly reduce the complication rate. Hussain et
al. [18] showed that PTCA with stent placement can be
performed in octogenarians with a high rate of clinical and
angiographic success with an acceptable range of morbidity
and mortality, and favorable long term (two year) outcome.
In this study, the extracardiac complications which are
frequent after surgical revascularization were limited, and
yet more important is the fact that no patient suﬀered a
cerebrovascular accident.
Followup results were encouraging. For 84 percent of
patients in our study who had clinical success after PTCA,
the long-term results continued to be beneﬁcial. Mortality
was relatively low and usually involved those patients with
triple vessel disease, low ejection fraction, and incomplete
revascularization. Jeroudi et al. [19] showed that survival at
one year was 81 percent and at three years, 80 percent. On
the other hand, Imburgia et al. [20] reported the lowest late
success rate. Of 26 patients who achieved clinical success,
only 11 had improved at followup. The diﬀerent long-term
results can be explained by the baseline clinical variables
pre-PTCA and the various degrees of revascularization
obtained. Some authors assert that patients with incomplete
revascularization obtained by PTCA have a higher rate of
symptoms and coronary bypass at followup than patients
who have had complete revascularization [21]. We identiﬁed
low LV function, diabetes and impaired renal function as
independent predictors of unfavorable outcome at long-
term followup. Bell et al. reported that survival of patients
with multivessel disease is inﬂuenced by the baseline clinical
variables but not the degree of revascularization [22]. The
CASS study [23] showed that survival of elderly patients was
inﬂuenced by both the left ejection fraction and also the
associated medical disease. Only a prospective randomized
study will answer the question of what treatment is best in
selected patients.
It can be hypothesized that if long-term outcome
depends on baseline clinical characteristics rather than
degree of revascularization, PTCA and stent can be a valid
therapeutic alternative even if the degree of revascularization
is lower.
3.5.1. Study Limitations. Our data come from a relatively
small sample size and were obtained in a single center. No
comparisonoftheresultsinthisolderpopulationtothelarge
volume of younger patients was obtained. However, some
important studies have demonstrated that this group of elder
patients has higher in-hospital mortality when comparing
with younger patients [12, 22].
4. Conclusions
Percutaneous coronary angioplasty is a valid therapeutic
alternative in elderly patients with coronary artery disease.
In selected patients with single and double vessel disease, the
short- and long-term outcome is very favorable. In patients
with triple vessel disease, the short-term results are less
favorable. However, these patients with triple vessel disease
and complete revascularization by PTCA have good long-
term outcome. Low LV function, diabetes, and impaired
renal function increase the risk of long-term major adverse
cardiac events.
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